HÀ NỘI — Human trials of Viet Nam’s second homegrown COVID-19 vaccine began at the Hà Nội Medical University in Hà Nội on Thursday.
COVIVAC has been developed by the Institute of Vaccines and Medical Biologicals (IVAC) in collaboration with several international universities, institutes and organisations since May 2020.
A ceremony to announce the beginning of trials was held on Thursday, where volunteers signed up for the trials.
IVAC director Dương Hữu Thái said preclinical studies were held in India, the US and Việt Nam. Results have shown safety and effectiveness, meeting full conditions for human trials.
“COVIVAC is a liquid vaccine with or without adjuvants and without preservatives. It is produced following the production technology of Newcastle disease vector (NDV), attached to the gene expressing Protein S of SARS-CoV-2 virus.
“It is developed based on embryonic production technology that is also used to produce seasonal influenza vaccines in Việt Nam,” said Thái.
According to Thái, IVAC facilities will be able to provide from 6 million to 30 million doses of COVIVAC vaccine yearly. The COVIVAC vaccine can be preserved in temperature conditions from 2-8 degrees Celsius while other international vaccines must be stored at -70 degrees Celsius.
The first phase of human trials will be carried out by the National Institute of Hygiene and Epidemiology and the Hà Nội Medical University. In the first phase, 120 healthy volunteers will be divided into five groups and receive either vaccine doses of 1 mcg, 3 mcg, 10 mcg, 1 mcg with adjuvant supplementation or a placebo.
The volunteers are aged between 18 and 59 years old, healthy and without any underlying health conditions. The first volunteer is expected to be given the first dose in February. The second dose will be administered 28 days later.
If the first phase shows positive results and meets safety standards, the second phase will be carried out with a larger sample scale. The first phase is expected to finish in April. The second phase is scheduled to be conducted in Vũ Thư District, Thái Bình Province in July this year.
In December last year, the Ministry of Health and the Military Medical Institute in collaboration with Nanogen Pharmaceutical Biotechnology Joint Stock Company launched clinical trials of the Nano Covax vaccine, the first locally-produced COVID-19 vaccine in Việt Nam. VNS
- Rollout of Johnson & Johnson Ebola vaccine begins in Congo
- Chinese scientist who claims he made world's first gene-edited babies says a SECOND pregnancy is underway as hospital where he performed the scandal-hit work accuses him of forgery
- Correction: Border Activist-Trial story
- Turkish judge refuses to throw out trial of student Pride marchers
- Michelle Bachelet: Torture survivor and former Chilean president begins role as UN rights chief
- Vaccine for the H7N9 Bird Flu: How Will We Know It Works?
- New dengue vaccine performs well in large trial, but safety remains key concern
- India's Homegrown Remedy Likely to Become World's First Cure for Dengue
- EXCLUSIVE: Revealed - the Filipino baby and teen mom at center of human trafficking claim: Utah woman posed as newborn's aunt 'to smuggle him to U.S. in her carry-on for Mormon blessing'
- Jeffrey Epstein is denied bail as judge cites 'moving' testimony of victims, pedophile's trove of underage nude photos and his 'uncontrollable' urge to sexually abuse minors in decision ordering him to prison ahead of trial
- Sheena Bora Trial: Indrani was a dark blob against a jail window
- Sheena Bora Trial: A Tale of Two Witnesses
Human trials of second homegrown COVID-19 vaccine begin have 622 words, post on vietnamnews.vn at January 22, 2021. This is cached page on Talk Vietnam. If you want remove this page, please contact us.
